Abstract
To evaluate the efficacy of cyclosporin A (CyA) for treating severe Henoch-Schönlein nephritis (HSN), seven patients with nephrotic syndrome, aged 3.9–13.8 years (mean 6.5 years), were analyzed retrospectively. Mean follow-up times were 5.5 years (range 2–9 years). All underwent renal biopsy before treatment, and follow-up renal biopsy was performed in six of the seven patients. All patients improved, with 24-h protein declining from a mean of 9.2 g/m2/day (range 1.5–16 g/m2/day) to 0.3 g/m2/day (range 0.03–1.2 g/m2/day) (p=0.016) and serum albumin increasing from a mean of 2.1 g/dl (range 1.5–2.4 g/dl) to 4.6 g/dl (range 3.5–5.3 g/dl) (p=0.016) after CyA therapy. The activity index decreased significantly at the second renal biopsies obtained at a mean interval of 11.7 months after the first (6.4±3.3 vs 3.5±1.2, p=0.042, respectively), while the chronicity index and the tubulointerstitial scores did not change. On the immunofluorescent findings at the second biopsies, the degree of deposits of immunoglobulins such as IgA, IgM, C3, and fibrinogen decreased in five of the six patients. Although this case series is without controls, our study suggests that CyA may be beneficial to a subset of HSN patients with nephrotic syndrome.
Similar content being viewed by others
References
Kaku Y, Nohara K, Honda S (1998) Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int 53:1755–1759
Austin HA, Balow JE (1983) Henoch-Schönlein nephritis: prognostic features and the challenge of therapy. Am J Kidney Dis 2:512–520
Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura. A retrospective cohort study. Lancet 360:666–670
Goldstein AR, White RHR, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282
Ronkainen J, Ala-Houhala M, Huttunen N-P, Jahnukainen T, Koskimies O, Örmälä T, Nuutinen M (2003) Outcome of Henoch-Schönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84
Ronkainen J, Autio-Harmainen H, Nuutinen M (2003) Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 18:1138–1142
Someya T, Kaneko K, Fujinaga S, Ohtaki R, Hira M, Yamashiro Y (2004) Cyclosporine A for heavy proteinuria in a child with Henoch-Schönlein purpura nephritis. Pediatr Int 46:111–113
Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11–14
Andreoli S, Bergstein J (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248–253
Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe HSP nephritis with prednisone and azathioprine: a clinical and histopathological study. J Pediatr 136:370–375
Meadow SR, Glasgow EF, White RHR, Moncrief MW, Cameron JS, Ogg CS (1972) Schönlein-Henoch nephritis. Q J Med 41:241–258
Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18:347–350
Davin J-C, Weening JJ (2001) Henoch-Schönlein purpura nephritis: an update. Eur J Pediatr 160:689–695
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch nephritis. Pediatr Nephrol 12:238–243
Bergstein J, Leiser J, Andreoli SP (1998) Response of crescentic HSP nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 49:9–14
Öner A, Tinaztepe K, Erdogan Ö (1995) The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 9:6–10
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244–248
Michael K, Jai R, Gerald A (1999) Cyclosporine treatment of glomerular diseases. Ann Rev Med 50:1–15
Singh S, Devidayal, Kumar L, Joshi K, Minz RW, Datta U (2002) Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 22:133–137
Sönmez F, Mir S, Cura A, Cakir D, Basdemir G (1999) Clinicopathologic correlations of Henoch-Schönlein nephritis in Turkish children. Pediatr Int 41:353–356
Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, Suzuki H (2003) Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 60:153–160
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shin, J.I., Park, J.M., Shin, Y.H. et al. Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome. Pediatr Nephrol 20, 1093–1097 (2005). https://doi.org/10.1007/s00467-005-1864-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-1864-2